AVEO Pharmaceuticals (AVEO) Tops Q1 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. SPY
3. LLY
4. TSLA
5. META
6. FICO
7. SPCX
8. MSFT
9. AZN
10. FLG

Go back to AVEO Pharmaceuticals (AVEO) Tops Q1 EPS by 4c

AVEO Oncology Reports First Quarter 2015 Financial Results

May 7, 2015 6:34 AM EDT

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- AVEO Oncology (NASDAQ: AVEO) today reported financial results for the first quarter ended March 31, 2015.

We continue to execute on our strategy of leveraging biomarker insights and exploring partnership opportunities to advance our pipeline, while continuing to streamline AVEOs operations to align with our needs, said Michael Bailey, president and chief executive officer. In parallel, we are evaluating three potential approaches to create value with tivozanib: first, the submission of a Marketing Authorization Application (MAA) for renal cell cancer (RCC) in Europe; second, a prospective study in colorectal cancer... More